Search research articles

Search research articles

Related Experiment Videos

Primary Sclerosing Cholangitis.

Young-Mee Lee¹, David J. Kim

¹Division of Gastroenterology, New England Medical Center, Tufts University School of Medicine, 750 Washington Street, Box 002, Boston, MA 02111, USA. ylee@lifespan.org

Current Treatment Options in Gastroenterology

|November 7, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Network Analysis of Sleep, Mental Health, and Stress in Korean Dentists.

International dental journal·2026

Same author

Learning planetary health through international & interprofessional education: a qualitative study of student reflections.

Medical education online·2026

Same author

Artificial intelligence-assisted shared decision-making training for medical students transitioning to residency.

Academic medicine : journal of the Association of American Medical Colleges·2026

Same author

Twelve tips for developing and implementing AI curriculum for undergraduate medical education.

Medical education online·2025

Same author

Integrating artificial intelligence into medical curricula: perspectives of faculty and students in South Korea.

Korean journal of medical education·2025

Same author

Evaluation of Burnout and Contributing Factors in Imaging Cardiologists in Korea.

Journal of Korean medical science·2025

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Currently, no definitive medical treatment exists for primary sclerosing cholangitis (PSC). Management focuses on symptom relief and preventing complications, with liver transplantation as the only definitive treatment for advanced disease.

Area of Science:

Hepatology
Gastroenterology
Autoimmune Diseases

Background:

Primary sclerosing cholangitis (PSC) is a chronic liver disease with no proven medical therapy.
Management focuses on alleviating cholestasis symptoms and preventing complications.
Known complications include vitamin deficiencies, osteopenia, biliary strictures, and cholangiocarcinoma.

Purpose of the Study:

To review current management strategies for primary sclerosing cholangitis.
To highlight the importance of managing PSC complications.
To discuss the role of medical therapies and liver transplantation.

Main Methods:

Review of existing literature on primary sclerosing cholangitis management.
Analysis of treatment outcomes for various medical therapies.

Related Experiment Videos

Evaluation of the role of liver transplantation in end-stage PSC.

Main Results:

No medical therapy has demonstrated an effect on survival or time to liver transplantation.
High-dose ursodeoxycholic acid shows promising preliminary results.
Liver transplantation is the only effective treatment for end-stage PSC.

Conclusions:

Current management of PSC is largely supportive, focusing on symptom and complication control.
While some therapies improve liver tests, they do not impact long-term outcomes.
Liver transplantation remains the definitive treatment for patients with end-stage disease.